NuvOx Pharma logo

NuvOx Pharma jobs and careers

About NuvOx Pharma

NuvOx Pharma develops a platform for drugs that upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ibready).

Founded in 2008 by Dr. Evan C. Unger.

Founded
2008
Employees
11 to 50
Total funding
$19M

Leadership

The top of NuvOx Pharma's org chart, with how many people report into each leader.

EUPhoto of Evan Unger

Evan Unger

Co-founder And CEO At Nuvox Therapeutics

3 reports

JJPhoto of Jennifer L.H. Johnson

Jennifer L.H. Johnson

Chief Operating Officer

2 reports